MSK e-Tumor Board: Early Detected, Low-Risk Prostate Cancer

Memorial Sloan Kettering physicians present an e-tumor board, which focuses on a patient, who is otherwise well, but has a prostate-specific antigen (PSA) test at 4.6. About six weeks later, the patients PSA was rechecked, and it was 5.0. The team discusses further testing and how to approach early, low risk prostate cancer.